(19)
(11) EP 4 025 596 A1

(12)

(43) Date of publication:
13.07.2022 Bulletin 2022/28

(21) Application number: 20861262.2

(22) Date of filing: 04.09.2020
(51) International Patent Classification (IPC): 
C07K 14/705(2006.01)
C07K 16/28(2006.01)
C07K 16/24(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/248; C07K 16/2866; C07K 14/70521; C07K 2319/30; A61K 2039/505; A61K 2039/55; A61K 2039/545
(86) International application number:
PCT/US2020/049422
(87) International publication number:
WO 2021/046361 (11.03.2021 Gazette 2021/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 04.09.2019 US 201962895836 P

(71) Applicant: Cedars-Sinai Medical Center
Los Angeles, CA 90048 (US)

(72) Inventors:
  • JORDAN, Stanley, C.
    Manhattan Beach, California 90266 (US)
  • VO, Ashley
    Northridge, California 91326 (US)
  • AMMERMAN, Noriko
    Los Angeles, California 90031 (US)
  • HUANG, Edmund
    Redondo Beach, California 90278 (US)
  • KIM, Irene
    Los Angeles, California 90048 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)

   


(54) USE OF CALCINEURIN INHIBITOR FREE CTLA4-IG + ANTI-IL6/IL6R FOR LONG TERM IMMUNOSUPPRESSION IN SOLID ORGAN TRANSPLANT RECIPIENTS